ESOPJun 5, 2026, 08:02 AM
Taysha Gene Therapies Grants 714,700 RSUs & 468,600 Stock Options
AI Summary
Taysha Gene Therapies announced that its Compensation Committee granted restricted stock units (RSUs) representing 714,700 shares and options to purchase 468,600 shares of common stock to four new employees. These inducement grants were made under the 2023 Inducement Plan, with RSUs vesting over four years and stock options vesting over four years at an exercise price of $5.97.
Key Highlights
- Taysha granted 714,700 restricted stock units (RSUs) to four new employees.
- Options to purchase 468,600 shares of common stock were also granted.
- The stock option exercise price is $5.97, equal to the closing price on the grant date.
- RSUs will vest in four equal annual installments.
- Stock options vest over four years, with 25% on the first anniversary.
- Grants were made under the 2023 Inducement Plan as employment inducements.
Price Impact
More from TSHA